Multi-Lingual Support From the Global MediXchange of Combating COVID-19 (GMCC) Programme to Further Enable Sharing Among Medical Personnel Worldwide
Over 440 medical institutions from 104 countries and regions have applied to learn and share experiences in battling COVID-19 through the International Medical Expert Communication Platform. The Handbook of COVID-19 Prevention and Treatment is now available in seven languages with more to come.
The platform, a centerpiece of the Global MediXchange for Combating COVID-19 (GMCC) program, was jointly established by the Jack Ma Foundation and Alibaba Foundation. It is designed for medical experts around the world to communicate seamlessly with each other to share their invaluable experience of fighting coronavirus disease 2019 (COVID-19) and to ask and answer each other’s questions. To date, the most applications have come in thus far from medical institutions in the U.S, Turkey, the U.K., Pakistan, Spain and Germany.
Medical staff need to apply and be approved to join the platform. Once they’re accepted, they’re free to participate in individual or group discussions and sessions.
“Knowledge is power! We launched an online platform for doctors and nurses around the world to exchange ideas, lessons and know-how to fight the virus. We welcome all hospitals to join Chinese hospitals on this open platform https://covid-19.alibabacloud.com. One world, one fight!" Jack Ma wrote in a tweet Wednesday.
Tapping Alibaba Group’s DingTalk messaging and communications functions, the digital platform provides free audio and video conference functionality, along with live broadcast functions for more-complex scenarios. Medical workers from different countries can choose to communicate with their fellow doctors individually, or they can participate in live-sharing group sessions to interact with multiple participants, using real-time artificial intelligence translation to overcome communication barriers. The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), for example, has been using the platform to share their valuable experience with 92 medical institutions from 44 countries and regions.
A playback function allows further sharing or posting on official websites for consumption anytime – and for those who can’t join the live broadcasts due to the time difference or if they are occupied by their duties.
To date, the International Medical Expert Communication Platform has attracted numerous Chinese medical institutions, including Zhongnan Hospital of Wuhan University (Wuhan Leishenshan Hospital), The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), and others.
Through video conferencing and AI translation from and into 11 languages (Arabic, Chinese, English, French, Indonesian, Japanese, Russian, Spanish, Thai, Turkish, and Vietnamese), the platform aims to build a virtual community.
DingTalk, which powers this platform, has also been tabbed by UNESCO as facilitating distance learning during the coronavirus outbreak.
Also as part of the GMCC programme, the Handbook of COVID-19 Prevention and Treatment, authored by The First Affiliated Hospital, Zhejiang University School of Medicine and compiled according to clinical experience, is now available at no cost in Chinese, English, French, Italian, Japanese, Turkish and Spanish. This handbook provides comprehensive guidelines and best practices by China's top experts for coping with COVID-19. More languages will be added soon, as the GMCC programme continues to launch more anti-epidemic resources and provide more practical suggestions and references for medical staff worldwide.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Esri Offers Students Free Access to Software for Continued Education Through Coronavirus Closures30.3.2020 16:29:00 EEST | Press release
Esri, the global leader in location intelligence, today announced that it will provide free access to its ArcGIS platform and learning resources through the Learn.ArcGIS.com website to support college and university students who no longer have access to campus computer labs during the COVID-19 outbreak. Students will receive access to ArcGIS Online and over 20 apps including ArcGIS Pro, along with a library of lessons to continue their learning and complete courses. Access is available globally to students ages 18 and over. Learn ArcGIS promotes learning by doing through guided lessons based on real-world problems in industries such as urban planning and disaster response, and new lessons on public health have just been added. Learn ArcGIS lessons cover both beginner and advanced topics and are available in seven languages. “We believe education creates opportunities for people of all ages, while building communities and advancing our knowledge for a better world,” said Jack Dangermond
Aptorum Group Collaborates with Covar Pharmaceuticals To Investigate at Least 3 Repurposed Drug Candidates (SACT-COV19) for Coronavirus Disease 2019 (COVID-19) under Existing Smart-ACT™ Platform and Acticule Infectious Disease Platform30.3.2020 15:00:00 EEST | Press release
Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs including but not limited to infectious, orphan and metabolic disease areas, today announced that it is initiating an additional research and development project targeting the coronavirus group and has completed initial screening under the Smart-ACT™ platform, a repurposed and new drug discovery platform, to select, out of more than 2,600 approved small drug molecules, at least 3 potential candidates for further preclinical investigation against the new coronavirus disease, COVID-19. Aptorum Group is collaborating with Toronto based Covar Pharmaceuticals and has also entered into agreement with the University of Hong Kong’s Microbiology Department to conduct further preclinical investigation of the selected candidates prior to seeking approval from regulatory agencies to initiate clinical trials on suitable candidates. In particular, Aptoru
Daiichi Sankyo Submits Application for CAR T Therapy Axicabtagene Ciloleucel for Treatment of Patients with Certain Relapsed/Refractory B-cell Lymphomas in Japan30.3.2020 15:00:00 EEST | Press release
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a New Drug Application (NDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW) for chimeric antigen receptor (CAR) T cell therapy axicabtagene ciloleucel for the treatment of adult patients with relapsed/refractory diffuse large B-cell lymphoma and related lymphomas. In January 2017, Daiichi Sankyo received exclusive development, manufacturing and commercialization rights for axicabtagene ciloleucel in Japan from California-based Kite, a Gilead Company. The Japan NDA submission is based on previous pivotal trial data conducted globally by Kite for axicabtagene ciloleucel in addition to results from a phase 2 bridging study conducted by Daiichi Sankyo in Japan. Both trials included patients with four aggressive types of relapsed/refractory B-cell lymphomas including diffuse large B cell lymphoma (DLBCL); primary mediastinal B-cell lymphoma (PMBCL); transformed follicular lymphoma (TF
HCL Technologies COVID-19 Status Update30.3.2020 11:40:00 EEST | Press release
HCL Technologies Ltd (HCL) has been monitoring the Covid-19 outbreak since late January and had invoked its Business Continuity Plan and Risk Management Framework quite early to minimize the impact on its employees and clients. The situation arising out of this outbreak and its rapid spread across the world is unprecedented and is extremely dynamic. The economic impact is visible with varying degrees of intensity across multiple countries where we operate. HCL has had a well-defined and structured pandemic policy in place which is resilient, pragmatic and accords paramount importance to employee safety & health and client commitments. We are actively engaged with our clients and have executed the client-specific and HCL internal operations-centric Business Continuity Plan that ensures continuity in delivering to our client and employee commitments. HCL is constantly reviewing the situation at hand with utmost priority and fully complying with all government advisories and recommendatio
GSMA Report Highlights That Mobile Money Accounts Now Exceed One Billion Worldwide30.3.2020 11:00:00 EEST | Press release
The GSMA today unveiled the annual ‘State of the Industry Report on Mobile Money’, offering a view of the mobile money landscape and highlighting the impact that greater financial inclusion has on lives, economies and innovation, especially in emerging markets. This year’s report looks at what one billion registered accounts means for the mobile money industry, mobile money users and the future of the mobile money ecosystem. It provides a comprehensive picture of adoption and usage around the globe. Significantly, the report highlights that 2019 marked a major milestone for the mobile money industry, with over one billion registered accounts and close to two billion dollars in daily transactions. For the first time, digital transactions represented the majority, 57 per cent, of mobile money interactions. The industry is witnessing increasing user trust and relevance. With 290 live services in 95 countries and 372 million active accounts, mobile money is entering the mainstream and beco
Rewired Targets Growth-Stage AI Ventures30.3.2020 10:00:00 EEST | Press release
Rewired, the robotics focused venture studio that invests in growth-stage technology ventures, is seeking to add new artificial intelligence and robotics investments to its portfolio. The portfolio currently encompasses innovations in machine learning, robotics, bionics, smart sensors, mapping and localization in the UK and USA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200330005016/en/ Backed by investors who believe that analysts are underestimating the prospects of AI, Rewired seeks to make investments of between $5m and $30m. Its status as a venture studio means that Rewired uniquely seeks to attain a substantial or majority position as an investor, and to then provide long term funding and expertise. The Rewired approach is to alleviate founders from the burden of constant fundraising so they can focus on growth, whilst avoiding the dilution that VC’s typically accept during multiple funding rounds. Rewired is seek
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom